TAXUS Paclitaxel-Eluting Coronary Stent
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAXUS Paclitaxel-Eluting Coronary Stent, covering 2010-08-06 to 2010-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions [Phase 2, Phase 3]